Barclays Initiates Coverage On Sabra Health Care REIT with Equal-Weight Rating, Announces Price Target of $21

Benzinga Newsdesk www.benzinga.com Neutral 50.7%

Neg 0% Neu 50.7% Pos 0%

Barclays analyst Richard Hightower initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight rating and announces Price Target of $21.